- Home
- MAIA vs AAME Comparison
MAIA vs AAME Comparison
Compare MAIA & AAME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAIA
- AAME
- Stock Information
- Founded
- MAIA 2018
- AAME 1968
- Country
- MAIA United States
- AAME United States
- Employees
- MAIA N/A
- AAME N/A
- Industry
- MAIA Biotechnology: Pharmaceutical Preparations
- AAME Life Insurance
- Sector
- MAIA Health Care
- AAME Finance
- Exchange
- MAIA Nasdaq
- AAME Nasdaq
- Market Cap
- MAIA 56.3M
- AAME 46.3M
- IPO Year
- MAIA 2022
- AAME N/A
- Fundamental
- Price
- MAIA $1.58
- AAME $3.08
- Analyst Decision
- MAIA
- AAME
- Analyst Count
- MAIA 0
- AAME 0
- Target Price
- MAIA N/A
- AAME N/A
- AVG Volume (30 Days)
- MAIA 398.8K
- AAME 25.2K
- Earning Date
- MAIA 08-11-2025
- AAME 08-12-2025
- Dividend Yield
- MAIA N/A
- AAME 0.65%
- EPS Growth
- MAIA N/A
- AAME N/A
- EPS
- MAIA N/A
- AAME 0.10
- Revenue
- MAIA N/A
- AAME $198,977,000.00
- Revenue This Year
- MAIA N/A
- AAME N/A
- Revenue Next Year
- MAIA N/A
- AAME N/A
- P/E Ratio
- MAIA N/A
- AAME $29.45
- Revenue Growth
- MAIA N/A
- AAME 6.98
- 52 Week Low
- MAIA $1.40
- AAME $1.25
- 52 Week High
- MAIA $3.74
- AAME $3.37
- Technical
- Relative Strength Index (RSI)
- MAIA 45.57
- AAME 78.68
- Support Level
- MAIA $1.50
- AAME $2.18
- Resistance Level
- MAIA $1.73
- AAME $2.38
- Average True Range (ATR)
- MAIA 0.09
- AAME 0.21
- MACD
- MAIA 0.01
- AAME 0.06
- Stochastic Oscillator
- MAIA 42.86
- AAME 76.09
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.
About AAME Atlantic American Corporation
Atlantic American Corp operates in specialty markets within the life and health and property and casualty insurance industries. The company has two segments: American Southern, It provides property and casualty insurance including bodily injury and property damage liability coverage, uninsured motorist coverage, and physical damage coverage for commercial accounts, and Bankers Fidelity, the company's life and health operations offer a variety of life and supplemental health products including ordinary and term life insurance, Medicare supplement, and other health insurance.